COAG 8-K 2026-11-10

Hemab Therapeutics Holdings, Inc. (COAG) 8-K dated 2026-11-10 — accession 0001193125-26-454414.

Hemab Therapeutics Holdings, Inc. (COAG) common stock.

Hemab Therapeutics Holdings, Inc. filed a 8-K on 2026-11-10. Accession 0001193125-26-454414.

This 8-K covers: Results of operations (Item 2.02), Exhibits (Item 9.01). SEC EDGAR holds the official filing and its exhibits.

Income-statement cache for COAG is thin on this filing URL. We will not invent exhibit numbers.

Not investment advice. The COAG SEC hub lists recent forms. The stock page is the research view.